UMR-106 Cells

UMR-106 is an osteosarcoma cell line derived from a rat model, commonly used in studies investigating bone metabolism, cancer biology, and osteoblast differentiation. These cells are highly responsive to parathyroid hormone (PTH), prostaglandins, and bone-resorbing steroids, making them valuable for research on the regulatory mechanisms of bone cells. The PTH responsiveness of UMR-106 cells is notably greater than that of the related cell line UMR-108, highlighting their unique utility in studies focused on PTH signaling pathways. UMR-106 cells also exhibit the production of alkaline phosphatase, osteocalcin, and other bone-related proteins, which are critical markers in osteoblast research.In cancer research, UMR-106 cells serve as a model to study the molecular mechanisms underlying osteosarcoma development and progression. They exhibit typical features of cancer cells, such as rapid proliferation and the ability to form tumors in vivo, allowing researchers to explore the genetic and epigenetic changes associated with osteosarcoma. These cells are also instrumental in preclinical studies for testing the efficacy and safety of new anti-cancer drugs, providing a reliable system for the preliminary evaluation of therapeutic agents.Furthermore, UMR-106 cells are utilized to investigate the pathways involved in osteoblast function and differentiation. Researchers have observed that activation of protein kinase C in UMR-106 cells inhibits ATP-induced increases in intracellular calcium levels, providing insights into the complex regulatory networks governing osteoblast activity. The responsiveness of these cells to various stimuli, along with their ability to produce key osteoblastic markers, makes UMR-106 a critical tool in the study of bone biology and the development of strategies to treat bone-related disorders.